Torrent Pharmaceuticals Share Price Today | Stock Price & Torrent Pharmaceuticals Share Screener

Track the current stock price of Torrent Pharmaceuticals with an interactive chart. Analyse TORNTPHARM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Torrent Pharmaceuticals stock quote in one place.

The quote of ₹4,558.70 sits between the 52-week low of ₹3,553.40 and the 52-week high of ₹5,122.80, and the latest session moved 0.00% from the previous close.

Screen Torrent Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TORNTPHARM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Sudhir Mehta listed as chairperson or CEO, and it trades under ISIN INE685A01028.

Torrent Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global presence. It specializes in cardiovascular, central nervous system, vitamins and nutrients, gastro-intestinal, and anti-diabetes therapies. The company operates through wholly-owned subsidiaries in over 40 countries, with major operations in the US, Germany, and Brazil. Torrent Pharmaceuticals has manufacturing...more

Classification

Identifiers and Leadership

Screen TORNTPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹44,312, up from ₹14,990 in 2025.

Latest statistics put total assets at ₹44,312 and shareholder funds at ₹17,585, with a leverage ratio of 1.14.

Screen Torrent Pharmaceuticals income statement and profit fundamentals. Analyze TORNTPHARM quarterly results. Torrent Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹4,111 and net profit was ₹364, equal to earnings per unit of ₹11.51, at an operating margin of 30%.

In that period expenses were ₹2,907, interest cost ₹236 and tax ₹165. The next period listed, 2025-Mar, shows revenue of ₹2,891 and net profit of ₹498.

Screen TORNTPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3,023, and net cash flow was an inflow of ₹544.

Over the same period, investing activities used ₹12,630 and financing activities provided ₹10,151.

See Torrent Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Torrent Pharmaceuticals promoter holding and ownership changes for TORNTPHARM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 68.31%, foreign institutions 16.18%, domestic institutions 9.06% and the public 4.12%, spread across 83,811 shareholders.

The shareholder count was 83,811 in 2026-Mar, compared with 85,776 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Torrent Pharmaceuticals. Torrent Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹38.00 per unit for 2026-March, a yield of 0.77%, compared with ₹32.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹38.00, ₹32.00 and ₹28.00 per unit.

See which indices include Torrent Pharmaceuticals stock. Check TORNTPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 32 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Get Torrent Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Torrent Pharmaceuticals stock events that may affect TORNTPHARM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 30, 2026, with a record date of July 30, 2026.

It is followed by Merger - Demerger dated July 17, 2026 and Annual General Meeting dated June 23, 2026.

Screen TORNTPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen TORNTPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 17, 2026.

The next most recent announcements are dated October 14, 2026 and October 14, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.